Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00660582 Org: User:
Start: 04/30/08 End: 02/28/13 Due: 02/28/14

Chemotherapy for Patients With Cancer of the Stomach

Phase: N/A Priority: Normal
NCT ID: NCT01928524 Org: User:
Start: 09/30/13 End: 12/17/15 Due: 12/17/16

Investigation of the Effect of Vitamin K3-lotion for the Treatment of Cetuximab Induced Folliculitis

Phase: N/A Priority: Normal
NCT ID: NCT01094444 Org: User:
Start: 05/31/10 End: 11/30/14 Due: 11/30/15

Stereotactic Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer (LAPC)

Phase: N/A Priority: Normal
NCT ID: NCT03648632 Org: User:
Start: 08/22/18 End: 03/31/22 Due: 03/31/23

A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01042028 Org: User:
Start: 01/31/10 End: 01/31/14 Due: 01/31/15

Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours

Phase: N/A Priority: Normal
NCT ID: NCT01397019 Org: User:
Start: 04/30/11 End: 02/28/18 Due: 02/28/19

Cetuximab in Combination With Chemotherapy for Patients With Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01020864 Org: User:
Start: 01/31/10 End: 01/31/12 Due: 01/31/13

Nordic 8 - A Phase II Trial

Phase: N/A Priority: Normal
NCT ID: NCT01867697 Org: User:
Start: 05/31/12 End: 03/31/19 Due: 03/31/20